0
We're unable to sign you in at this time. Please try again in a few minutes.
Retry
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
Retry
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
Other Articles |

HEMORRHAGIC PERICARDITIS IN ACUTE MYOCARDIAL INFARCTION TREATED WITH BISHYDROXYCOUMARIN

Robert Goldstein, M.D.; Louis Wolff, M.D.
JAMA. 1951;146(7):616-621. doi:10.1001/jama.1951.03670070008004.
Text Size: A A A
Published online

The reports of the Committee for the Evaluation of Anticoagulants in the Treatment of Coronary Thrombosis with Myocardial Infarction, American Heart Association, and several other reports1 have indicated the efficacy of anticoagulant therapy in acute myocardial infarction. The drug of choice at the present time is bishydroxycoumarin (dicumarol®). Its toxicity has been studied in animals,2 and the hemorrhagic complications that occur clinically have been reported. It is the purpose of this communication to call attention to an unusual and serious hemorrhagic complication heretofore unreported and to emphasize the clinical signs that make possible early recognition of this complication.

REPORT OF CASES 

Case 1.  —This was the first admission to the hospital of a 42 year old white man, who entered with severe substernal pain of one hour's duration. He had had no previous history of exertional dyspnea, chest pain, peripheral edema, diabetes or hypertension. On the morning of

Topics

Sign in

Purchase Options

• Buy this article
• Subscribe to the journal
• Rent this article ?

First Page Preview

View Large
First page PDF preview

Figures

Tables

References

CME
Also Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
Please click the checkbox indicating that you have read the full article in order to submit your answers.
Your answers have been saved for later.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.

Multimedia

Some tools below are only available to our subscribers or users with an online account.

8 Views
0 Citations

Sign in

Purchase Options

• Buy this article
• Subscribe to the journal
• Rent this article ?

Related Content

Customize your page view by dragging & repositioning the boxes below.

Jobs
×
brightcove.createExperiences();